Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation

Abstract

Pluripotent stem cells can be genetically labeled to facilitate differentiation studies. In this paper, we describe a gene-targeting protocol to knock in a GFP cassette into key gene loci in human pluripotent stem cells (hPSCs), and then use the genetically tagged hPSCs to guide in vitro differentiation, immunocytochemical and electrophysiological profiling and in vivo characterization after cell transplantation. The Olig transcription factors have key roles in the transcription regulatory pathways for the genesis of motor neurons (MNs) and oligodendrocytes (OLs). We have generated OLIG2-GFP hPSC reporter lines that reliably mark MNs and OLs for monitoring their sequential differentiation from hPSCs. The expression of the GFP reporter recapitulates the endogenous expression of OLIG genes. The in vitro characterization of fluorescence-activated cell sorting-purified cells is consistent with cells of the MN or OL lineages, depending on the stages at which they are collected. This protocol is efficient and reliable and usually takes 5–7 months to complete. The genetic tagging-differentiation methodology used herein provides a general framework for similar work for differentiation of hPSCs into other lineages.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The gene-targeting strategy at the OLIG2 locus.
Figure 2: Long-range genomic PCR to screen for homologous recombinants in OLIG2-GFP gene targeting.
Figure 3: Flowchart of the differentiation of motor neurons (MNs) and oligodendrocyte precursor cells (OPCs) from OLIG2-GFP knock-in hESCs.
Figure 4: Representative current-clamp recording traces from the OLIG2-GFP knock-in hESC-derived GFP-positive motor neurons.
Figure 5: OLIG2-GFP knock-in hESCs give rise to OPCs that later generate mature oligodendrocytes.
Figure 6: GFP-expressing cells differentiated into oligodendrocytes after transplantation into rat spinal cords.

Similar content being viewed by others

References

  1. Lu, Q.R. et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109, 75–86 (2002).

    Article  CAS  Google Scholar 

  2. Zhou, Q. & Anderson, D.J. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109, 61–73 (2002).

    Article  CAS  Google Scholar 

  3. Lee, S.K., Lee, B., Ruiz, E.C. & Pfaff, S.L. Olig2 and Ngn2 function in opposition to modulate gene expression in motor neuron progenitor cells. Genes Dev. 19, 282–294 (2005).

    Article  CAS  Google Scholar 

  4. Wang, S.Z. et al. An oligodendrocyte-specific zinc-finger transcription regulator cooperates with Olig2 to promote oligodendrocyte differentiation. Development 133, 3389–3398 (2006).

    Article  CAS  Google Scholar 

  5. Deneen, B. et al. The transcription factor NFIA controls the onset of gliogenesis in the developing spinal cord. Neuron 52, 953–968 (2006).

    Article  CAS  Google Scholar 

  6. Xue, H. et al. A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. Stem Cells 27, 1836–1846 (2009).

    Article  CAS  Google Scholar 

  7. Jiang, P. et al. Electrophysiological properties of human induced pluripotent stem cells. Am. J. Physiol. Cell Physiol. 298, C486–C495 (2010).

    Article  CAS  Google Scholar 

  8. Jiang, P., Selvaraj, V. & Deng, W. Differentiation of embryonic stem cells into oligodendrocyte precursors. J. Vis. Exp., doi:10.3791/1960 (2010).

  9. Zou, J. et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5, 97–110 (2009).

    Article  CAS  Google Scholar 

  10. Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851–857 (2009).

    Article  CAS  Google Scholar 

  11. Song, H., Chung, S.K. & Xu, Y. Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell 6, 80–89 (2010).

    Article  CAS  Google Scholar 

  12. Davis, R.P. et al. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 111, 1876–1884 (2008).

    Article  CAS  Google Scholar 

  13. Ruby, K.M. & Zheng, B. Gene targeting in a HUES line of human embryonic stem cells via electroporation. Stem Cells 27, 1496–1506 (2009).

    Article  CAS  Google Scholar 

  14. Hu, B.Y., Du, Z.W., Li, X.J., Ayala, M. & Zhang, S.C. Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects. Development 136, 1443–1452 (2009).

    Article  CAS  Google Scholar 

  15. Hu, B.Y., Du, Z.W. & Zhang, S.C. Differentiation of human oligodendrocytes from pluripotent stem cells. Nat. Protoc. 4, 1614–1622 (2009).

    Article  CAS  Google Scholar 

  16. Watanabe, K. et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681–686 (2007).

    Article  CAS  Google Scholar 

  17. Liu, Y. et al. Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development. Glia 40, 25–43 (2002).

    Article  Google Scholar 

  18. Campanelli, J.T. et al. Expression profiling of human glial precursors. BMC Dev. Biol. 8, 102 (2008).

    Article  Google Scholar 

  19. Cummins, T.R., Rush, A.M., Estacion, M., Dib-Hajj, S.D. & Waxman, S.G. Voltage-clamp and current-clamp recordings from mammalian DRG neurons. Nat. Protoc. 4, 1103–1112 (2009).

    Article  CAS  Google Scholar 

  20. Wu, S., Ying, G., Wu, Q. & Capecchi, M.R. A protocol for constructing gene targeting vectors: generating knockout mice for the cadherin family and beyond. Nat. Protoc. 3, 1056–1076 (2008).

    Article  CAS  Google Scholar 

  21. Davis, R.P. et al. A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis. Nat. Protoc. 3, 1550–1558 (2008).

    Article  CAS  Google Scholar 

  22. Costa, M. et al. A method for genetic modification of human embryonic stem cells using electroporation. Nat. Protoc. 2, 792–796 (2007).

    Article  CAS  Google Scholar 

  23. Li, X.J. et al. Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells 26, 886–893 (2008).

    Article  CAS  Google Scholar 

  24. Hu, B.Y. & Zhang, S.C. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat. Protoc 4, 1295–1304 (2009).

    Article  CAS  Google Scholar 

  25. Li, X.J. et al. Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 23, 215–221 (2005).

    Article  Google Scholar 

  26. Sinha, S. & Chen, J.K. Purmorphamine activates the Hedgehog pathway by targeting Smoothened. Nat. Chem. Biol. 2, 29–30 (2006).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the California Institute for Regenerative Medicine (CIRM, RT1-01107-1 to Y.L.), the National Institutes of Health (R01NS061983 and R01ES015988 to W.D.), the National Multiple Sclerosis Society (to W.D.) and by Shriners Hospitals for Children (to W.D.). P.J. is a recipient of a postdoctoral fellowship from Shriners Hospitals for Children. Y.L. thanks H. Xue for technical assistance; J. Loring, L. Laurent and M. Rao for support; B. Ranscht (Sanford-Burnham Medical Research Institute) for the GalC antibody; and the CIRM shared laboratory at the Scripps Research Institute for providing accommodation and facilities.

Author information

Authors and Affiliations

Authors

Contributions

Y.L., P.J. and W.D. designed the experiments, and wrote and finally approved the manuscript.

Corresponding authors

Correspondence to Ying Liu or Wenbin Deng.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Y., Jiang, P. & Deng, W. OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation. Nat Protoc 6, 640–655 (2011). https://doi.org/10.1038/nprot.2011.310

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nprot.2011.310

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing